Koers Orchid Ventures, Inc. Canadian Securities Exchange
Aandelen
ORCD
CA68573L2066
Farmaceutische producten
Omzet 2020 | 1,45 1,97 1,34 | Omzet 2021 | 3,72 5,06 3,44 | Marktkapitalisatie | 10,45 mln. 14,23 mln. 9,67 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -6 mln. -8,17 mln. -5,55 mln. | Nettowinst (verlies) 2021 | -3 mln. -4,08 mln. -2,77 mln. | EV/omzet 2020 | 2.373.049 x |
Nettoschuld 2020 | 363K 495K 336K | Nettoliquiditeiten 2021 | 1 mln. 1,37 mln. 928K | EV/omzet 2021 | 2.540.035 x |
K/w-verhouding 2020 |
-0,45
x | K/w-verhouding 2021 |
-2,02
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 79,11% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Corey Mangold
CEO | Chief Executive Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Corey Mangold
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+54,07% | 809 mld. | |
+38,95% | 621 mld. | |
-7,05% | 351 mld. | |
+15,44% | 319 mld. | |
+5,72% | 289 mld. | |
+14,43% | 238 mld. | |
-0,41% | 221 mld. | |
+14,73% | 218 mld. | |
+7,42% | 166 mld. |